The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10x Genomics Inc | CL A COM | 88025U109 | 82,405 | 660,933 | SH | SOLE | 1,2,3 | 660,933 | 0 | 0 | |
Acutus Medical Inc | COM | 005111109 | 13,465 | 451,834 | SH | SOLE | 1,2,3 | 451,834 | 0 | 0 | |
Adaptimmune Therapeutics PLC | SPONDS ADR | 00653A107 | 20,889 | 2,617,626 | SH | SOLE | 1,2,3 | 2,617,626 | 0 | 0 | |
Adverum Biotechnologies Inc | COM | 00773U108 | 74,518 | 7,234,764 | SH | SOLE | 1,2,3 | 7,234,764 | 0 | 0 | |
Agenus Inc | COM NEW | 00847G705 | 51,459 | 12,864,677 | SH | SOLE | 1,2,3 | 12,864,677 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 244,848 | 1,681,645 | SH | SOLE | 1,2,3 | 1,681,645 | 0 | 0 | |
Altimmune Inc | COM NEW | 02155H200 | 17,621 | 1,334,940 | SH | SOLE | 1,2,3 | 1,334,940 | 0 | 0 | |
Amyris Inc | COM NEW | 03236M200 | 15,071 | 5,161,347 | SH | SOLE | 1,2,3 | 5,161,347 | 0 | 0 | |
Apyx Medical Corp | COM | 03837C106 | 15,973 | 3,391,279 | SH | SOLE | 1,2,3 | 3,391,279 | 0 | 0 | |
Arbutus Biopharma Corp | COM | 03879J100 | 18,712 | 5,978,355 | SH | SOLE | 1,2,3 | 5,978,355 | 0 | 0 | |
Arcturus Therapeutics Ltd | COM | 03969T109 | 10,778 | 251,236 | SH | SOLE | 1,2,3 | 251,236 | 0 | 0 | |
argenx SE | SPONSORED ADR | 04016X101 | 8,336 | 31,752 | SH | SOLE | 1,2 | 31,752 | 0 | 0 | |
Arya Sciences Acquisition Corp | COM CL A | G3166W106 | 5,408 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Arya Sciences Acquisition II Corp | UNIT 06/09/2027 | G31655114 | 5,500 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Athira Pharma Inc | COM | 04746L104 | 45,372 | 2,668,913 | SH | SOLE | 1,2,3 | 2,668,913 | 0 | 0 | |
Avadel Pharmaceuticals plc | SPONSORED ADR | 05337M104 | 27,048 | 5,366,705 | SH | SOLE | 1,2,3 | 5,366,705 | 0 | 0 | |
Avidity Biosciences Inc | COM | 05370A108 | 109,888 | 3,995,000 | SH | SOLE | 1,2,3 | 3,995,000 | 0 | 0 | |
Axonics Modulation Technologies Inc | COM | 05465P101 | 96,152 | 1,883,864 | SH | SOLE | 1,2,3 | 1,883,864 | 0 | 0 | |
Axsome Therapeutics Inc | COM | 05464T104 | 119,054 | 1,670,938 | SH | SOLE | 1,2,3 | 1,670,938 | 0 | 0 | |
Baxter International Inc | COM | 071813109 | 86,634 | 1,077,268 | SH | SOLE | 1,2,3 | 1,077,268 | 0 | 0 | |
BCTG Acquisition Corp | COM | 05492W103 | 6,216 | 600,000 | SH | SOLE | 1,2,3 | 600,000 | 0 | 0 | |
Bellus Health Inc | COM NEW | 07987C204 | 9,547 | 4,195,356 | SH | SOLE | 1,2,3 | 4,195,356 | 0 | 0 | |
Berkeley Lights Inc | COM | 084310101 | 22,934 | 300,338 | SH | SOLE | 1,2,3 | 300,338 | 0 | 0 | |
BiomX Equities Warrant Exp 13 Dec 2023 | *W EXP 10/16/202 | 09090D111 | 426 | 600,000 | SH | SOLE | 1,2 | 600,000 | 0 | 0 | |
Biomx Inc | COM | 09090D103 | 3,804 | 600,000 | SH | SOLE | 1,2 | 600,000 | 0 | 0 | |
Brainsway Ltd | SPONSORED ADS | 10501L106 | 6,459 | 1,107,420 | SH | SOLE | 1,2,3 | 1,107,420 | 0 | 0 | |
Burning Rock Biotech Ltd | SPONSORED ADS | 12233L107 | 752 | 30,000 | SH | SOLE | 1,2,3 | 30,000 | 0 | 0 | |
Castle Biosciences Inc | COM | 14843C105 | 38,260 | 743,642 | SH | SOLE | 1,2,3 | 743,642 | 0 | 0 | |
Celldex Therapeutics Inc | COM NEW | 15117B202 | 46,272 | 3,120,137 | SH | SOLE | 1,2,3 | 3,120,137 | 0 | 0 | |
Cerner Corp | COM | 156782104 | 100,631 | 1,392,049 | SH | SOLE | 1,2,3 | 1,392,049 | 0 | 0 | |
Chardan Healthcare Acquisition 2 Corp | UNIT 99/99/9999 | 15957T206 | 3,588 | 350,000 | SH | SOLE | 1,2,3 | 350,000 | 0 | 0 | |
Clearside Biomedical Inc | COM | 185063104 | 6,079 | 3,947,518 | SH | SOLE | 1,2,3 | 3,947,518 | 0 | 0 | |
Cytokinetics Inc Private | COM NEW | 23282W605 | 40,702 | 2,000,000 | SH | SOLE | 1,2,3 | 2,000,000 | 0 | 0 | |
Cytomx Therapeutics Inc | COM | 23284F105 | 10,148 | 1,526,003 | SH | SOLE | 1,2,3 | 1,526,003 | 0 | 0 | |
DermTech Inc | COM | 24984K105 | 34,502 | 2,887,215 | SH | SOLE | 1,2,3 | 2,887,215 | 0 | 0 | |
Dicerna Pharmaceuticals Inc | COM | 253031108 | 130,021 | 7,227,413 | SH | SOLE | 1,2,3 | 7,227,413 | 0 | 0 | |
Equillium Inc | COM | 29446K106 | 5,798 | 1,004,784 | SH | SOLE | 1,2,3 | 1,004,784 | 0 | 0 | |
Establishment Labs Holdings Inc | COM | G31249108 | 42,974 | 2,319,138 | SH | SOLE | 1,2,3 | 2,319,138 | 0 | 0 | |
Exagen Inc | COM | 30068X103 | 13,551 | 1,250,131 | SH | SOLE | 1,2,3 | 1,250,131 | 0 | 0 | |
Frequency Therapeutics Inc | COM | 35803L108 | 47,285 | 2,461,486 | SH | SOLE | 1,2,3 | 2,461,486 | 0 | 0 | |
Fulcrum Therapeutics Inc | COM | 359616109 | 9,124 | 1,150,565 | SH | SOLE | 1,2,3 | 1,150,565 | 0 | 0 | |
GenMark Diagnostics Inc | COM | 372309104 | 10,835 | 762,994 | SH | SOLE | 1,2,3 | 762,994 | 0 | 0 | |
Guardant Health Inc | COM | 40131M109 | 52,480 | 469,498 | SH | SOLE | 1,2,3 | 469,498 | 0 | 0 | |
Homology Medicines Inc | COM | 438083107 | 26,942 | 2,517,906 | SH | SOLE | 1,2,3 | 2,517,906 | 0 | 0 | |
Illumina Inc | COM | 452327109 | 54,089 | 175,000 | SH | SOLE | 1,2,3 | 175,000 | 0 | 0 | |
Immatics Nv | SHS | N44445109 | 3,714 | 350,000 | SH | SOLE | 1,2,3 | 350,000 | 0 | 0 | |
Immunic Inc | COM | 4525EP101 | 16,945 | 912,496 | SH | SOLE | 1,2,3 | 912,496 | 0 | 0 | |
Immunovant Inc | COM | 45258J102 | 264,291 | 7,510,412 | SH | SOLE | 1,2,3 | 7,510,412 | 0 | 0 | |
Incyte Corp | COM | 45337C102 | 29,986 | 334,144 | SH | SOLE | 1,2,3 | 334,144 | 0 | 0 | |
Inmode Ltd | SHS | M5425M103 | 9,045 | 250,000 | SH | SOLE | 1,2 | 250,000 | 0 | 0 | |
Itamar Medical Ltd | SPONSORED ADS | 465437101 | 9,341 | 457,218 | SH | SOLE | 1,2,3 | 457,218 | 0 | 0 | |
Iteos Therapeutics Inc | COM | 46565G104 | 20,904 | 902,855 | SH | SOLE | 1,2,3 | 902,855 | 0 | 0 | |
IVERIC bio Inc | COM | 46583P102 | 37,582 | 6,663,439 | SH | SOLE | 1,2,3 | 6,663,439 | 0 | 0 | |
Johnson & Johnson | COM | 478160104 | 22,296 | 149,761 | SH | SOLE | 1,2 | 149,761 | 0 | 0 | |
La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 9,652 | 2,395,029 | SH | SOLE | 1,2,3 | 2,395,029 | 0 | 0 | |
Lifesci Acquisition Corp | UNIT 03/31/2025 | 53228P208 | 6,800 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
MacroGenics Inc | COM | 556099109 | 31,621 | 1,255,299 | SH | SOLE | 1,2,3 | 1,255,299 | 0 | 0 | |
Masimo Corp | COM | 574795100 | 106,319 | 450,390 | SH | SOLE | 1,2,3 | 450,390 | 0 | 0 | |
Milestone Pharmaceuticals Inc | COM | 59935V107 | 31,587 | 4,315,102 | SH | SOLE | 1,2,3 | 4,315,102 | 0 | 0 | |
MiMedx Group Inc | COM | 602496101 | 17,161 | 2,700,320 | SH | SOLE | 1,2,3 | 2,700,320 | 0 | 0 | |
Mirati Therapeutics Inc | COM | 60468T105 | 181,992 | 1,096,005 | SH | SOLE | 1,2,3 | 1,096,005 | 0 | 0 | |
Myokardia Inc | COM | 62857M105 | 127,732 | 936,931 | SH | SOLE | 1,2,3 | 936,931 | 0 | 0 | |
NanoString Technologies Inc | COM | 63009R109 | 42,337 | 947,134 | SH | SOLE | 1,2,3 | 947,134 | 0 | 0 | |
Natera Inc | COM | 632307104 | 123,586 | 1,710,769 | SH | SOLE | 1,2,3 | 1,710,769 | 0 | 0 | |
Odonate Therapeutics Inc | COM | 676079106 | 13,420 | 999,256 | SH | SOLE | 1,2,3 | 999,256 | 0 | 0 | |
OraSure Technologies Inc | COM | 68554V108 | 25,254 | 2,075,082 | SH | SOLE | 1,2,3 | 2,075,082 | 0 | 0 | |
Outset Medical Inc | COM | 690145107 | 20,250 | 405,000 | SH | SOLE | 1,2,3 | 405,000 | 0 | 0 | |
Oyster Point Pharma Inc | COM | 69242L106 | 40,613 | 1,923,893 | SH | SOLE | 1,2,3 | 1,923,893 | 0 | 0 | |
Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | 3,600 | 300,000 | SH | SOLE | 1,2,3 | 300,000 | 0 | 0 | |
Personalis Inc | COM | 71535D106 | 5,526 | 255,000 | SH | SOLE | 1,2 | 255,000 | 0 | 0 | |
Pmv Pharmaceuticals Inc | COM | 69353Y103 | 17,750 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Profound Medical Corp | COM NEW | 74319B502 | 4,308 | 244,193 | SH | SOLE | 1,2,3 | 244,193 | 0 | 0 | |
Progenity Inc | COM | 74319F107 | 2,481 | 275,000 | SH | SOLE | 1,2,3 | 275,000 | 0 | 0 | |
ProQR Therapeutics NV | SHS EURO | N71542109 | 23,822 | 4,973,174 | SH | SOLE | 1,2,3 | 4,973,174 | 0 | 0 | |
Protagonist Therapeutics Inc | COM | 74366E102 | 66,645 | 3,408,961 | SH | SOLE | 1,2,3 | 3,408,961 | 0 | 0 | |
PTC Therapeutics Inc | COM | 69366J200 | 186,686 | 3,993,286 | SH | SOLE | 1,2,3 | 3,993,286 | 0 | 0 | |
Regenxbio Inc | COM | 75901B107 | 8,763 | 318,434 | SH | SOLE | 1,2,3 | 318,434 | 0 | 0 | |
Relmada Therapeutics Inc | COM | 75955J402 | 56,857 | 1,511,337 | SH | SOLE | 1,2,3 | 1,511,337 | 0 | 0 | |
Rocket Pharmaceuticals Inc | COM | 77313F106 | 384,334 | 16,812,491 | SH | SOLE | 1,2,3,4 | 16,812,491 | 0 | 0 | |
Stoke Therapeutics Inc | COM | 86150R107 | 118,697 | 3,544,248 | SH | SOLE | 1,2,3 | 3,544,248 | 0 | 0 | |
Tandem Diabetes Care Inc | COM NEW | 875372203 | 68,495 | 603,481 | SH | SOLE | 1,2,3 | 603,481 | 0 | 0 | |
Tela Bio Inc | COM | 872381108 | 22,805 | 1,378,776 | SH | SOLE | 1,2,3 | 1,378,776 | 0 | 0 | |
Therapeutics Acquisition Corp | COM CL A | 88339T103 | 7,046 | 490,000 | SH | SOLE | 1,2,3 | 490,000 | 0 | 0 | |
Translate Bio Inc | COM | 89374L104 | 50,973 | 3,745,286 | SH | SOLE | 1,2,3 | 3,745,286 | 0 | 0 | |
Transmedics Group Inc | COM | 89377M109 | 6,935 | 503,266 | SH | SOLE | 1,2 | 503,266 | 0 | 0 | |
Trillium Therapeutics Inc | COM NEW | 89620X506 | 30,705 | 2,160,800 | SH | SOLE | 1,2,3 | 2,160,800 | 0 | 0 | |
Twist Bioscience Corp | COM | 90184D100 | 1,403 | 18,473 | SH | SOLE | 1,2,3 | 18,473 | 0 | 0 | |
Uniqure NV | SHS | N90064101 | 5,837 | 158,479 | SH | SOLE | 1,2,3 | 158,479 | 0 | 0 | |
Vaxart Inc | COM NEW | 92243A200 | 23,390 | 3,517,345 | SH | SOLE | 1,2,3 | 3,517,345 | 0 | 0 | |
Vericel Corp | COM | 92346J108 | 71,356 | 3,850,851 | SH | SOLE | 1,2,3 | 3,850,851 | 0 | 0 |